A. V. Zinkina-Orikhan

The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study

N. V. Lomakin, G. Musaev, Elena S. Pasechnik et al. · Inflammation Research · 2021 · 53 citations · Full text

Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial

L. Puig, Maria Morozova, Nikita A. Zolkin et al. · Dermatology and Therapy · 2021 · 36 citations · Full text

Long-term efficacy and safety of netakimab in the treatment of ankylosing spondylitis: results of Phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA

Mazurov Vi, I. Z. Gaydukova, N. Soroka et al. · Modern Rheumatology Journal · 2020 · 17 citations · Full text

Long-term Efficacy, Pharmacotherapy, Dermatology +20

Efficacy and safety of levilimab in combination with methotrexate in subjects with rheumatoid arthritis: Results of phase II AURORA study

Mazurov Vi, E. G. Zotkin, I. Z. Gaydukova et al. · Rheumatology Science and Practice · 2021 · 17 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +14

Effectiveness and safety of levilimab in combination with methotrexate in treatment of patients with active rheumatoid arthritis resistant to methotrexate monotherapy (double-blinded randomized placebo controlled phase III clinical study SOLAR)

Mazurov Vi, A. M. Prystrom, N. Soroka et al. · Modern Rheumatology Journal · 2021 · 14 citations · Full text

Rheumatoid Disorder, Rheumatology, Week 24 +14